Managed Healthcare Executive May 3, 2024
Research is highlighting how GLP-1 is expressed in prostate cancer, suggesting that GLP-1 agonists might have a future role in the management of this cancer.
Diabetes, weight loss and now possibly cancer. Glucagon-like peptide-1 (GLP-1) is a hormone secreted by intestinal cells that leads to insulin secretion through the GLP-1 receptor. Available therapies that target GLP-1 are known for their roles in treating diabetes and obesity and reducing the risk of cardiovascular disease.
One day, GLP-1 agonists might even be used to treat prostate cancer. Several recent studies have highlighted the role of GLP-1 in prostate cancer, giving hope that this could present a new way to treat this disease.
The most recent study is a poster presented at the...
Today's Sponsors
Today's Sponsor